Jun Nakashima

5.1k total citations
173 papers, 4.1k citations indexed

About

Jun Nakashima is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Jun Nakashima has authored 173 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Pulmonary and Respiratory Medicine, 46 papers in Surgery and 38 papers in Oncology. Recurrent topics in Jun Nakashima's work include Prostate Cancer Diagnosis and Treatment (49 papers), Prostate Cancer Treatment and Research (43 papers) and Bladder and Urothelial Cancer Treatments (23 papers). Jun Nakashima is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (49 papers), Prostate Cancer Treatment and Research (43 papers) and Bladder and Urothelial Cancer Treatments (23 papers). Jun Nakashima collaborates with scholars based in Japan, United States and Germany. Jun Nakashima's co-authors include Masaru Murai, Masaaki Tachibana, Takashi Ohigashi, Yoshio Ohno, Makoto Ohori, Mototsugu Oya, Yutaka Horiguchi, Akira Miyajima, Tadashi Hatano and Ken Marumo and has published in prestigious journals such as Cancer, Clinical Cancer Research and Kidney International.

In The Last Decade

Jun Nakashima

169 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Nakashima Japan 35 1.7k 1.1k 1.0k 800 638 173 4.1k
Takahiro Kimura Japan 31 1.7k 1.0× 790 0.7× 945 0.9× 1.3k 1.7× 811 1.3× 325 4.0k
Takefumi Satoh Japan 33 1.6k 0.9× 665 0.6× 546 0.5× 878 1.1× 441 0.7× 157 3.6k
Shiro Baba Japan 38 1.8k 1.1× 659 0.6× 1.8k 1.8× 977 1.2× 396 0.6× 285 4.8k
Juan Moróte Spain 37 2.8k 1.6× 1.1k 1.0× 1.0k 1.0× 1.1k 1.4× 675 1.1× 358 4.8k
Matthias D. Hofer United States 33 1.6k 0.9× 549 0.5× 793 0.8× 1.4k 1.7× 639 1.0× 121 3.9k
Edouard J. Trabulsi United States 33 2.3k 1.3× 841 0.8× 1.3k 1.3× 552 0.7× 494 0.8× 201 4.0k
Lutz Trojan Germany 27 1.9k 1.1× 537 0.5× 662 0.7× 1.0k 1.3× 321 0.5× 129 3.4k
Francisco Civantos United States 43 1.9k 1.1× 1.2k 1.1× 1.9k 1.9× 498 0.6× 263 0.4× 136 4.8k
John A. Libertino United States 40 2.4k 1.4× 518 0.5× 1.8k 1.8× 1.5k 1.9× 638 1.0× 184 4.7k
Michael R. Harrison United States 37 2.9k 1.7× 1.8k 1.7× 1.7k 1.7× 928 1.2× 611 1.0× 176 6.1k

Countries citing papers authored by Jun Nakashima

Since Specialization
Citations

This map shows the geographic impact of Jun Nakashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Nakashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Nakashima more than expected).

Fields of papers citing papers by Jun Nakashima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Nakashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Nakashima. The network helps show where Jun Nakashima may publish in the future.

Co-authorship network of co-authors of Jun Nakashima

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Nakashima. A scholar is included among the top collaborators of Jun Nakashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Nakashima. Jun Nakashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hashimoto, Takeshi, Yoshio Ohno, Jun Nakashima, et al.. (2015). Prediction of renal function after nephroureterectomy in patients with upper tract urothelial carcinoma. Japanese Journal of Clinical Oncology. 45(11). 1064–1068. 13 indexed citations
2.
Matsumoto, Kazuhiro, Ryuichi Mizuno, Nobuyuki Tanaka, et al.. (2014). Optimal timing of hormonal therapy for prostate-specific antigen recurrence after radical prostatectomy. Medical Oncology. 31(7). 45–45. 5 indexed citations
3.
Ohno, Yoshio, Jun Nakashima, Yoshihiro Nakagami, et al.. (2013). Clinical Implications of Preoperative Serum Total Cholesterol in Patients With Clear Cell Renal Cell Carcinoma. Urology. 83(1). 154–158. 26 indexed citations
4.
Nakashima, Jun, Etsuo Kunieda, Hirohiko Nagata, et al.. (2012). Preimplant Factors Affecting Prostate D90 after Transperineal Interstitial Prostate Brachytherapy with Loose 125I Seeds. The Keio Journal of Medicine. 61(3). 89–94. 2 indexed citations
5.
Hashimoto, Takeshi, Yoshio Ohno, Jun Nakashima, et al.. (2012). Clinical significance of preoperative peripheral blood neutrophil count in patients with non-metastatic upper urinary tract carcinoma. World Journal of Urology. 31(4). 953–958. 33 indexed citations
6.
Gondo, Tatsuo, Makoto Ohori, Ayako Tanaka, et al.. (2011). The efficacy and safety of gemcitabine plus cisplatin regimen for patients with advanced urothelial carcinoma after failure of M-VAC regimen. International Journal of Clinical Oncology. 16(4). 345–351. 8 indexed citations
7.
Ide, Hiroki, Jun Nakashima, Eiji Kikuchi, et al.. (2009). Prognostic Stratification in Patients Who Received Hormonal Therapy for Prostate-specific Antigen Recurrence after Radical Prostatectomy. Japanese Journal of Clinical Oncology. 40(2). 177–180. 3 indexed citations
8.
Mizuno, Ryuichi, Jun Nakashima, Makio Mukai, et al.. (2009). Tumour length of the largest focus predicts prostate‐specific antigen‐based recurrence after radical prostatectomy in clinically localized prostate cancer. British Journal of Urology. 104(9). 1215–1218. 24 indexed citations
9.
Ozu, Choichiro, Jun Nakashima, Yutaka Horiguchi, et al.. (2008). Prediction of bone metastases by combination of tartrate‐resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer. International Journal of Urology. 15(5). 419–422. 43 indexed citations
10.
Nakashima, Jun, Eiji Kikuchi, Akira Miyajima, et al.. (2008). Simple Stratification of Survival Using Bone Scan and Serum C-Reactive Protein in Prostate Cancer Patients with Metastases. Urologia Internationalis. 80(2). 129–133. 22 indexed citations
11.
Kosaka, Takeo, Akira Miyajima, Eiji Kikuchi, et al.. (2008). The Novel NF-κB Activation Inhibitor Dehydroxymethyl-Epoxyquinomicin Suppresses Anti-Thy1.1-Induced Glomerulonephritis in Rats. Nephron Experimental Nephrology. 110(1). e17–e24. 16 indexed citations
12.
Tanimoto, Akihiro, et al.. (2006). Prostate cancer screening: The clinical value of diffusion‐weighted imaging and dynamic MR imaging in combination with T2‐weighted imaging. Journal of Magnetic Resonance Imaging. 25(1). 146–152. 272 indexed citations
13.
Tanimoto, Akihiro, et al.. (2006). Prostate MR imaging for patients with elevated serum PSA levels. The clinical value of diffusion-weighted and dynamic MR imaging in cancer screening. 26(1). 52–57. 1 indexed citations
14.
Horiguchi, Akio, Jun Nakashima, Yutaka Horiguchi, et al.. (2003). Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer. The Prostate. 56(1). 23–29. 36 indexed citations
15.
Nakashima, Jun, et al.. (2001). Characterization of a newly established cell line derived from human adrenocortical carcinoma. International Journal of Urology. 8(1). 17–22. 5 indexed citations
16.
Yazaki, Takahito, Takashi Ohigashi, Y. Horiguchi, et al.. (2000). Application of Conditionally Replicating Herpes Vector for Gene Therapy Treatment of Urologic Neoplasms. PubMed. 4(2). 83–87. 2 indexed citations
17.
Kosugi, Michio, Hirohiko Nagata, Jun Nakashima, Masaru Murai, & Junichi Hata. (2000). A CASE OF METANEPHRIC ADENOMA TREATED WITH PARTIAL NEPHRECTOMY. The Japanese Journal of Urology. 91(4). 489–492. 8 indexed citations
18.
Nakashima, Jun, Makoto Sumitomo, Akira Miyajima, et al.. (1997). The value of serum carboxyterminal propeptide of type 1 procollagen in predicting bone metastases in prostate cancer.. PubMed. 157(5). 1736–9. 13 indexed citations
19.
Tachibana, Masaaki, Ayako Miyakawa, Jun Nakashima, et al.. (1997). Constitutive production of multiple cytokines and a human chorionic gonadotrophin beta-subunit by a human bladder cancer cell line (KU-19-19): possible demonstration of totipotential differentiation. British Journal of Cancer. 76(2). 163–174. 45 indexed citations
20.
Nakashima, Jun, Yutaka Horiguchi, Munehisa Ueno, et al.. (1995). Establishment of a Human Cell Line Secreting Neuron‐specific Enolase from a Primitive Neuroectodermal Tumor of the Retroperitoneal Cavity. Japanese Journal of Cancer Research. 86(12). 1172–1178. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026